Susquehanna International Group
BSX icon

Susquehanna International Group’s Boston Scientific BSX Stock Holding History

Susquehanna International Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$178M Buy
2,829,000
+1,078,800
+62% +$86.3M 0.02% 564
2025
Q4 		$167M Sell
1,750,200
-699,400
-29% -$68.6M 0.02% 609
2025
Q3 		$239M Buy
2,449,600
+896,500
+58% +$92.8M 0.03% 476
2025
Q2 		$167M Buy
1,553,100
+403,700
+35% +$40.8M 0.02% 519
2025
Q1 		$116M Sell
1,149,400
-720,400
-39% -$72.5M 0.02% 588
2024
Q4 		$167M Sell
1,869,800
-480,100
-20% -$42.3M 0.03% 488
2024
Q3 		$197M Buy
2,349,900
+1,572,700
+202% +$124M 0.03% 402
2024
Q2 		$59.9M Buy
777,200
+22,700
+3% +$1.66M 0.01% 867
2024
Q1 		$51.7M Sell
754,500
-24,700
-3% -$1.59M 0.01% 1013
2023
Q4 		$45M Sell
779,200
-1,704,700
-69% -$91M 0.01% 1108
2023
Q3 		$131M Buy
2,483,900
+1,120,100
+82% +$58.7M 0.03% 496
2023
Q2 		$73.8M Buy
1,363,800
+411,800
+43% +$21.5M 0.02% 767
2023
Q1 		$47.6M Buy
952,000
+395,000
+71% +$18.6M 0.01% 980
2022
Q4 		$25.8M Buy
557,000
+84,000
+18% +$3.64M 0.01% 1311
2022
Q3 		$18.3M Sell
473,000
-251,500
-35% -$10.1M ﹤0.01% 1499
2022
Q2 		$27M Buy
724,500
+12,700
+2% +$517K 0.01% 1220
2022
Q1 		$31.5M Sell
711,800
-1,135,100
-61% -$49.2M 0.01% 1313
2021
Q4 		$78.5M Sell
1,846,900
-37,600
-2% -$1.58M 0.01% 835
2021
Q3 		$81.8M Buy
1,884,500
+749,400
+66% +$33.2M 0.01% 883
2021
Q2 		$48.5M Buy
1,135,100
+339,900
+43% +$14.3M 0.01% 1225
2021
Q1 		$30.7M Sell
795,200
-799,600
-50% -$30.3M ﹤0.01% 1459
2020
Q4 		$57.3M Sell
1,594,800
-352,500
-18% -$12.7M 0.01% 929
2020
Q3 		$74.4M Sell
1,947,300
-733,700
-27% -$28.3M 0.01% 683
2020
Q2 		$94.1M Buy
2,681,000
+1,305,700
+95% +$47M 0.02% 528
2020
Q1 		$44.9M Buy
1,375,300
+747,400
+119% +$29.2M 0.01% 699
2019
Q4 		$28.4M Buy
627,900
+157,600
+34% +$6.59M 0.01% 1149
2019
Q3 		$19.1M Buy
470,300
+200
+0% +$8.47K 0.01% 1359
2019
Q2 		$20.2M Buy
470,100
+160,300
+52% +$6.17M 0.01% 1267
2019
Q1 		$11.9M Buy
309,800
+160,900
+108% +$6.15M ﹤0.01% 1583
2018
Q4 		$5.26M Sell
148,900
-163,600
-52% -$5.93M ﹤0.01% 2234
2018
Q3 		$12M Sell
312,500
-386,200
-55% -$13.5M ﹤0.01% 1758
2018
Q2 		$22.8M Buy
698,700
+334,000
+92% +$10.1M 0.01% 1196
2018
Q1 		$9.96M Sell
364,700
-9,900
-3% -$269K ﹤0.01% 1777
2017
Q4 		$9.29M Buy
374,600
+290,500
+345% +$8.01M ﹤0.01% 1888
2017
Q3 		$2.45M Sell
84,100
-38,800
-32% -$1.07M ﹤0.01% 3542
2017
Q2 		$3.41M Sell
122,900
-160,800
-57% -$4.27M ﹤0.01% 2952
2017
Q1 		$7.06M Buy
283,700
+43,900
+18% +$1.07M ﹤0.01% 1986
2016
Q4 		$5.19M Buy
239,800
+27,600
+13% +$602K ﹤0.01% 2378
2016
Q3 		$5.05M Buy
212,200
+17,100
+9% +$408K ﹤0.01% 2220
2016
Q2 		$4.56M Buy
195,100
+21,700
+13% +$469K ﹤0.01% 2329
2016
Q1 		$3.26M Sell
173,400
-108,900
-39% -$1.91M ﹤0.01% 2935
2015
Q4 		$5.21M Sell
282,300
-13,600
-5% -$244K ﹤0.01% 2488
2015
Q3 		$4.86M Buy
295,900
+31,000
+12% +$530K ﹤0.01% 2710
2015
Q2 		$4.69M Sell
264,900
-222,300
-46% -$3.97M ﹤0.01% 3014
2015
Q1 		$8.65M Sell
487,200
-587,500
-55% -$9.28M ﹤0.01% 2021
2014
Q4 		$14.2M Buy
1,074,700
+749,300
+230% +$9.58M 0.01% 1643
2014
Q3 		$3.84M Sell
325,400
-174,400
-35% -$2.2M ﹤0.01% 3444
2014
Q2 		$6.38M Buy
499,800
+5,400
+1% +$70.2K ﹤0.01% 2710
2014
Q1 		$6.68M Sell
494,400
-792,300
-62% -$10.4M ﹤0.01% 2508
2013
Q4 		$15.5M Buy
1,286,700
+720,600
+127% +$8.51M 0.01% 1620
2013
Q3 		$6.65M Buy
566,100
+340,400
+151% +$3.68M ﹤0.01% 2349
2013
Q2 		$2.09M Buy
+225,700
New +$1.91M ﹤0.01% 3834

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group's BSX Position: Q1 2026 in Review

Susquehanna International Group increased its Boston Scientific (BSX) stake by 86% in Q1 2026, buying an estimated $38.2M and bringing the position to 1,033,109 shares worth $64.8M. The position accounts for 0.01% of the portfolio, ranked #1095.

Susquehanna International Group first reported a position in BSX in Q2 2013 and has held it in 47 quarters since. The position peaked at $75.4M in Q1 2023. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Susquehanna International Group held 1,033,109 shares of Boston Scientific worth $64.8M as of Q1 2026.
  • Susquehanna International Group bought 477,139 Boston Scientific shares in Q1 2026, an estimated $38.2M.
  • Boston Scientific made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1095 holding.
  • Susquehanna International Group first reported a position in Boston Scientific in Q2 2013 and has held it in 47 quarters since.
  • Susquehanna International Group's Boston Scientific position peaked at $75.4M in Q1 2023.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.